Announcements 2021-22

Home / Announcements 2021-22

Announcement under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 – Revoked deal for selling stake in Subsidiary 24-09-2021

Allotment of 6,00,000 Equity Shares on Preferential Basis 16-09-2021

Communication to the shareholders w.r.t. TDS on Dividend 14-09-2021

Received product registration licenses for ten products in Turkmenistan 14–09-2021

Announcement under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 – Selling of Stake in Subsidiary 11-09-2021

Voting Results of Extraordinary General Meeting held on September 07, 2021 08-09-2021

Outcome of Extraordinary General Meeting held on September 07, 2021 07-09-2021

Newspaper Advertisement for Public Notice of 21st Annual General Meeting 05-09-2021

Notice of 21st Annual General Meeting 02-09-2021

Notice of Book Closure for Final Dividend and 21st Annual General Meeting 02-09-2021

Newspaper Advertisements for Extraordinary General Meeting to be held on September 07, 2021 17-08-2021

Newspaper Advertisements for Public Notice of Extraordinary General Meeting 14-08-2021

Newspaper Advertisements for Extract of Unaudited Financial Results for the Quarter ended June 30, 2021 31-07-2021

Capacity Addition at Company’s manufacturing plant at Surat Special Economic Zone 09-07-2021

Received Product Registration licenses for nine products from the Ministry of Health, Cambodia 06-07-2021

Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2021 06-07-2021

Annual Secretarial Compliance Report for the year ended March 31, 2021 30-06-2021

Notice for Closure of Trading Window 29-06-2021

List of Related Party Transactions for the half year and year ended March 31, 2021 28-06-2021

Newspaper Advertisement for Extract of Audited Financial Results for Quarter and Year Ended March 31, 2021 28-06-2021

Received product registration license for one product from the Ministry of Health, Bolivia 21-05-2021

Press Release – Davaindia Performance in Q4FY21 14-04-2021

Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2021

Received product registration licenses for two products from the Ministry of Health, Cambodia 05-04-2021

Disclosure under Regulation 30(1), 30(2) and 31(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 for the year ended on March 31, 2021 03-04-2021

Initial Disclosure for Large Entity 03-04-2021

Annual Disclosure for Large Entity 02-04-2021